Adhoc News

Please find here all Adhoc News of Marinomed.

19.05.2022
Marinomed Biotech AG enters into license agreement with Procter & Gamble on Carragelose® products

Adhoc-Announcement

04.10.2021
Marinomed Biotech AG signs financing agreement with Nice & Green S.A. to advance its scientific and clinical programs

Adhoc-Announcement

19.02.2021
Marinomed Biotech AG shares positive clinical trial results for iota-carrageenan nasal spray in the prevention of COVID-19

Adhoc-Announcement

16.07.2020
Marinomed Biotech AG: Carragelose® effective against SARS-CoV-2 in cell culture assays

Adhoc-Announcement

Stephanie Kniep, Dipl.-Ök.
Head of Investor Relations
Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com
Lucia Mayr-Harting, MSc
Public Relations
Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com